GlassScriptPhysician profile
David G Nelson
NPI 1720109796
$1,755.91
in general payments reported to CMS, 2019-2025
24 companies · $252 in 2025
The $252 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.50 · 2020: $106 · 2021: $686 · 2022: $212 · 2023: $126 · 2024: $301 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $301.19 | 2020-2022 | |
| Exeltis, USA INC. | $293.36 | 2020-2025 | Slynd, Twirla |
| Organon LLC | $207.86 | 2022-2025 | Nexplanon |
| Aspira Women'S Health INC | $157.55 | 2021 | |
| Lumenis, INC | $126.62 | 2021 | |
| Biogen, INC. | $93.52 | 2024 | Zurzuvae |
| Minerva Surgical, INC | $71.36 | 2021-2023 | |
| Hologic Sales and Service, LLC | $57.96 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.28 | 2019-2022 | |
| Novo Nordisk INC | $49.79 | 2020-2025 | Ozempic, Rybelsus |
| Applied Medical Resources Corporation | $48.01 | 2021 | |
| Therapeuticsmd, INC. | $46.65 | 2019-2022 | |
| Astellas Pharma US INC | $42.65 | 2023-2024 | Veozah |
| Merck Sharp & Dohme LLC | $41.76 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $25.16 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $22.26 | 2020 | |
| Allergan, INC. | $19.95 | 2019 | |
| Millicent US INC | $18.67 | 2025 | Intrarosa, Femlyv |
| Boston Scientific Corporation | $15.71 | 2024 | Wavewriter Alpha Prime 16 |
| Avion Pharmaceuticals | $15.57 | 2022 | |
| Sumitomo Pharma America, INC. | $14.84 | 2024 | Myfembree |
| Olympus America INC. | $13.38 | 2024 | 4k Cable 8.5m |
| Urovant Sciences INC | $11.79 | 2022 | |
| Kinex Medical Company LLC | $4.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.